Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Colitis, Ulcerative
Clinical trial register · France

Colitis, Ulcerative Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9714 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
9714
Studies in scope
all four open statuses
6038
Recruiting now
open to new participants
1027
Lead sponsors
across recruiting studies
Top sites
Lille 6 Paris 5 Montpellier 4 Nantes 4 Amiens 3

Colitis, Ulcerative trials in France

15 of 9714 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Observational
800
Amiens, Besançon
2026-09-17
Recruiting
Pfizer
Phase 2
24
Bron, Paris
2026-05-28
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Amiens, Besançon, Clichy, Créteil, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes
2026-05-23
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Lens, Nantes
2026-03-24
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Limoges, Montfermeil, Montpellier
2025-10-01
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Marseille, Nantes, Nice, Pierre-Bénite, Saint-Etienne
2025-05-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,380
Nice, Neuilly-sur-Seine, Vandœuvre-lès-Nancy, Lille
2024-11-25
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Lille
2024-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bron, Dijon, Lille, Paris, Toulouse
2024-01-19
Active, closed
Sanofi
Phase 2
187
Marseille, Nantes, Neuilly-sur-Seine, Vandœuvre-lès-Nancy
2022-11-25
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Amiens, Colombes, Créteil, Grenoble, La Roche-sur-Yon, Lille, Marseille, Montpellier
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Besançon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Nîmes, Pessac, Pierre-Bénite
2022-09-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
120
Toulouse, Bron, Caen, Paris
2022-05-30
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
159
Paris
2021-10-18
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bordeaux, Paris
2018-10-29
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-france/condition/colitis-ulcerative

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Colitis, Ulcerative.

How many Colitis, Ulcerative trials are recruiting in France?

8 of the 15 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Colitis, Ulcerative), 15 studies
PhaseStudiesRecruitingShare
Phase 38353.3%
Phase 25333.3%
Observational116.7%
Phase 2/3116.7%

Most active sponsors

Lead sponsors with the most studies (Colitis, Ulcerative)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC82
Merck Sharp & Dohme LLC22
Bristol-Myers Squibb11
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives11
Pfizer11
Sanofi10
Spyre Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.